BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36073295)

  • 1. Evaluating awareness, knowledge and practice of healthcare professionals following implementation of a revised pregnancy prevention programme for isotretinoin in Ireland: A multi-stakeholder cross-sectional study.
    Hughes JE; Buckley N; Looney Y; Kirwan G; Mullooly M; Bennett KE
    Pharmacoepidemiol Drug Saf; 2023 Feb; 32(2):137-147. PubMed ID: 36073295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness, knowledge and practice of healthcare professionals following implementation of a Pregnancy Prevention Program for sodium valproate in Ireland: a multi-stakeholder cross-sectional study.
    Hughes JE; Buckley N; Looney Y; Kirwan G; Curran S; Doherty CP; Mullooly M; Bennett KE
    Expert Opin Drug Saf; 2021 Aug; 20(8):965-977. PubMed ID: 34080507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium.
    Lelubre M; Hamdani J; Senterre C; Amighi K; Peres M; Schneider MP; Bugnon O; De Vriese C
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):668-673. PubMed ID: 29726056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.
    Crijns I; Mantel-Teeuwisse A; Bloemberg R; Pinas E; Straus S; de Jong-van den Berg L
    Expert Opin Drug Saf; 2013 Jan; 12(1):29-38. PubMed ID: 23163396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
    Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
    Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPs' practice and attitudes to initiating isotretinoin for acne vulgaris in Ireland: a cross-sectional questionnaire survey in primary care.
    Carmody K; Rouse M; Nolan D; Quinlan D
    Br J Gen Pract; 2020 Sep; 70(698):e651-e656. PubMed ID: 32784222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies.
    Crijns I; Straus S; Luteijn M; Gispen-de Wied C; Raine J; de Jong-van den Berg L
    Drug Saf; 2012 Jan; 35(1):27-32. PubMed ID: 22050373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies.
    Lagan BM; Dolk H; White B; Uges DR; Sinclair M
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):411-8. PubMed ID: 24493556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Awareness and Adherence of the Valproate Pregnancy Prevention Program: A Questionnaire Survey among Healthcare Professionals, Pharmacists, and Patients in Denmark.
    Oliveri NMB; Hansen JM; Almarsdóttir AB; Jacobsen R
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review.
    Crijns HJ; Straus SM; Gispen-de Wied C; de Jong-van den Berg LT
    Br J Dermatol; 2011 Feb; 164(2):238-44. PubMed ID: 20716214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacist's' knowledge and practice toward oral isotretinoin prescription: a systemic review.
    Rashid ZA; Al-Tabakha MM; Alomar MJ
    Pharmazie; 2020 Mar; 75(2):56-60. PubMed ID: 32213235
    [No Abstract]   [Full Text] [Related]  

  • 12. Knowledge on the Use of Isotretinoin and Its Side Effects and Awareness towards Saudi FDA-Pregnancy Prevention Program among the Female Acne Patients: A Northern Saudi Study.
    Alshaalan ZM
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363566
    [No Abstract]   [Full Text] [Related]  

  • 13. Awareness of isotretinoin use and Saudi FDA pregnancy prevention program in Riyadh, Saudi Arabia: A cross-sectional study among female patients.
    Ibrahim AAM; Alshatri AA; Alsuwaidan S; Almutairi L; Aljasser N; Mahmoud MA; Alaseeri A; Almonysir A; Alotaibi B; Alrasheed B; Alfawaz M
    Saudi Pharm J; 2021 Jun; 29(6):527-532. PubMed ID: 34194259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Assessment of the Knowledge of Oral Isotretinoin (Roaccutane) Treatment Among Pharmacy Students in Saudi Arabia.
    Malebari AM; Bakhsh HT; Musairi RM; Alghamdi JO; Alhaddad AA
    Cureus; 2023 Jun; 15(6):e40388. PubMed ID: 37456447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isotretinoin (Roaccutane) in women of childbearing age: failure of following prescription guidelines].
    Autret E; Radal M; Jonville-Béra AP; Goehrs JM
    Ann Dermatol Venereol; 1997; 124(8):518-22. PubMed ID: 9740842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study.
    Crijns HJ; van Rein N; Gispen-de Wied CC; Straus SM; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2012 Oct; 21(10):1060-6. PubMed ID: 22228673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland.
    O'Callaghan J; Bermingham M; Leonard M; Hallinan F; Morris JM; Moore U; Griffin BT
    Regul Toxicol Pharmacol; 2017 Aug; 88():252-261. PubMed ID: 28666961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study.
    de Vries ST; van der Sar MJM; Coleman AM; Escudero Y; Rodríguez Pascual A; Maciá Martínez MÁ; Cupelli A; Baldelli I; Šipić I; Andrić A; Michan L; Denig P; Mol PGM;
    Drug Saf; 2018 Jul; 41(7):713-724. PubMed ID: 29500798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacists' knowledge of isotretinoin safety.
    Alrwisan AA; Alshammari TM; Tahir KW; Aleissa FM; Aljadhey HS
    Saudi Med J; 2014 Jan; 35(1):81-4. PubMed ID: 24445895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotretinoin exposure during pregnancy: a population-based study in The Netherlands.
    Zomerdijk IM; Ruiter R; Houweling LM; Herings RM; Sturkenboom MC; Straus SM; Stricker BH
    BMJ Open; 2014 Nov; 4(11):e005602. PubMed ID: 25392022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.